Advanced Urology Institute Recognized as an Axonics® Center of Excellence

Dr. Carole Gordon is an expert at treating bladder and bowel dysfunction with innovative Axonics Therapy

April 20, 2021

Advanced Urology Institute has been designated an Axonics Center of Excellence by Axonics Modulation Technologies, Inc. The designation recognizes the AUI team and Dr. Carole Gordon for her expertise with Axonics Therapy and sincere commitment to changing the lives of patients suffering from bladder and bowel dysfunction.

Today, millions of Americans suffer from overactive bladder and fecal incontinence.1 Patients in the Villages, Leesburg, and Ocala areas with chronic and debilitating symptoms related to bladder and bowel dysfunction may seek treatment from the experts at AUI. Axonics Therapy gently stimulates the sacral nerve (sacra neuromodulation), restoring normal communication between the brain and the bladder. Axonics Therapy has been clinically proven to provide rapid and long-lasting relief of symptoms associated with bladder and bowel dysfunction.

In a clinical study, 129 patients with urgency incontinence were treated with Axonics Therapy At 2-years, 93% of patients had successful therapy and 94% of patients were satisfied with theirtherapy.2

The Axonics Center of Excellence program recognizes highly trained and experienced physicians (typically urologists, urogynecologists, and colorectal surgeons) and clinical practices that are committed to patient education and providing exemplary care to achieve optimal clinical outcomes and patient satisfaction.

“AUI is proud to be recognized as a Center of Excellence. This designation is a testament to the dedication of our entire team, and in particular to Dr. Carole Gordon,” said Gina Barnes, Chief Administrative Officer. “We are committed to providing the best care to our patients and are extremely pleased to offer Axonics Therapy.”

About Advanced Urology Institute

As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient-centered care.

For more information contact AUI at: 855-977-4888

About Axonics Modulation Technologies, Inc. and Sacral Neuromodulation

Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life.

Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit

References: 1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int.  2011;108(7):1132-1138. 2. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [in press]. Neurourol Urodyn. 2021.

Advanced Urology Institute Names Scott B. Sellinger, MD as AUI President


October 30, 2020

NAME: Miriam Williams, CAO
PHONE: (850) 348-2944
EMAIL: [email protected]


Michael S. Grable, MD will step down at the end of 2020

OXFORD, FL, October 30, 2020 — Advanced Urology Institute is proud to announce that Dr. Scott B. Sellinger will become president in 2021.

He brings a wealth of experience and accomplishments to the position. Raised in upstate New York, Dr. Sellinger graduated from Syracuse University in 1982 with a Bachelor of Science degree in chemistry. After moving to Gainesville, he attended the University of Florida School of Medicine and graduated with honors in 1986.He completed his surgical internship and urological residency at UF. In 1987, he was named as Surgical Intern of the Year and in 1989 received the prestigious Harris Award for the outstanding urology resident.

He replaces Dr. Michael S. Grable, who is transitioning out of his role at the end of 2020 to spend more time away from the practice. Dr. Grable became president of Advanced Urology Institute in 2013 during the formative stages of the practice. His vision and leadership skills helped transform AUI into the successfully and highly respected practice it is today.

The AUI board of directors unanimously voted Dr. Sellinger as his replacement.

“It is my honor and privilege to serve as your next AUI president effective January 1, 2021,” says Dr. Sellinger. “Please help me thank Dr. Mike Grable for his six plus years of service as president of our organization. Under his strong guidance and leadership, AUI has become one of the largest independent urology groups in the country. I look forward to many more years of growth and prosperity, and most importantly, standing tall on our commitment to world-class, patient-centered care.”

Dr. Sellinger was president of Capital Medical Society in 2003 and served as president of the Florida Urological Society in 2005. He is past president of the Southeastern Section of the American Urological Association and is immediate past president of the American Association of Clinical Urologists (AACU). In addition, he has served on the board of directors for the Large Urology Group Practice Association (LUPGA) for the past six years. Dr. Sellinger has developed a special interest in risk management and prevention of medical errors and has lectured extensively on these subject matters during the past several years.

“Dr. Grable has kept our AUI organization consistently focused on our AUI mission of patient-centered care throughout his presidency, which has been the linchpin of our success,” says AUI CEO Richard Wooten. “I am certain that Dr. Sellinger will continue to guide our AUI organization to greater heights. We welcome Dr. Sellinger as our second AUI president.”

About Advanced Urology Institute:
Headquartered in Oxford, FL, Advanced Urology Institute (AUI) is a professional corporation of medical doctors (M.D.’s) who are board-certified and qualified in the surgical sub-specialty of urology. In addition to Oxford, AUI specialists are located throughout Florida in Ocala, Panama City, Tallahassee, Daytona Beach, St. Petersburg, Clearwater, Fort Meyers, and Naples. AUI was founded in 2014 as a single-specialty, physician led organization to respond more efficiently and effectively to the ever-mounting changes in healthcare and government regulations. This allows AUI to provide and dedicate the highest level in patient-centered care with over 600 providers, clinical and front office staff. Learn more at